Atlas Trials

Aadi Bioscience, Inc.

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Aadi Bioscience, Inc.

RecordFirmDate
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer (NCT05997017)Aadi Bioscience, Inc.2023-12-28
Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors (NCT05997056)Aadi Bioscience, Inc.2023-11-07
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment (NCT05661461)Aadi Bioscience, Inc.2022-11-23
ABI-009 (Nab-sirolimus) in Patients With Genetically-confirmed Leigh or Leigh-like Syndrome (NCT03747328)Aadi Bioscience, Inc.2022-04-30
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) (NCT05103358)Aadi Bioscience, Inc.2022-02-15
Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma (NCT03463265)Aadi Bioscience, Inc.2018-08-01
Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer (NCT03439462)Aadi Bioscience, Inc.2018-07-01

Track Aadi Bioscience, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.